Comparison of the Diagnostic Performance of CBNAAT/Xpert Assay and Histopathology of Genital Tissue in Female Genital Tuberculosis
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Ajaykumar M. Patel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Female genital tuberculosis (FGTB) is an important cause of infertility and menstrual disorders, but its diagnosis remains challenging because of its paucibacillary nature and nonspecific clinical presentation. Histopathology is commonly used for diagnosis but has limited sensitivity, while CBNAAT/Xpert MTB/RIF offers rapid molecular detection of Mycobacterium tuberculosis. This study compared the diagnostic performance of CBNAAT with histopathological examination of genital tissue in clinically suspected FGTB.
Methods
A prospective observational study was conducted on 188 women with clinically suspected FGTB over a two-year period at a tertiary care hospital. Endometrial and other genital tissue specimens were subjected to both histopathological examination and CBNAAT testing, with histopathology considered the reference standard. Diagnostic indices including sensitivity, specificity, positive predictive value, and negative predictive value were calculated.
Results
The mean age of participants was 29.8 years, with primary infertility being the most common presentation (42.0%). Histopathology confirmed female genital tuberculosis in 4 (2.1%) patients. CBNAAT correctly identified 3 of the 4 histopathology-positive cases and yielded 2 false-positive results. Compared with histopathology, CBNAAT demonstrated a sensitivity of 75.0%, specificity of 98.9%, positive predictive value of 60.0%, and negative predictive value of 99.5%.
Conclusion
CBNAAT demonstrated high specificity and excellent negative predictive value, supporting its role as a rapid adjunctive diagnostic tool for female genital tuberculosis. However, its moderate sensitivity indicates that it should be interpreted in conjunction with histopathological and clinical findings, and larger multicentric studies are needed to further validate its diagnostic performance.
Zitieren
APA
Patel, A. M., Patel, K. A., & Patel, F. J. (2026). Comparison of the Diagnostic Performance of CBNAAT/Xpert Assay and Histopathology of Genital Tissue in Female Genital Tuberculosis. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.38
Vancouver
Patel AM, Patel KA, Patel FJ. Comparison of the Diagnostic Performance of CBNAAT/Xpert Assay and Histopathology of Genital Tissue in Female Genital Tuberculosis. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.38
BibTeX
@article{Patel2026,
author = {Patel, Ajaykumar M. and Patel, Kartik Aravindbhai and Patel, Foram Jasvantbhai},
title = {Comparison of the Diagnostic Performance of CBNAAT/Xpert Assay and Histopathology of Genital Tissue in Female Genital Tuberculosis},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.38}
}
EUVIMED